Shattuck Market Capitalization from 2010 to 2025

STTK Stock  USD 1.27  0.17  11.81%   
Shattuck Labs Market Cap yearly trend continues to be quite stable with very little volatility. The value of Market Cap is projected to decrease to about 331.8 M.
Check Shattuck Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shattuck Labs' main balance sheet or income statement drivers, such as Net Interest Income of 5.6 M, Interest Income of 5.6 M or Depreciation And Amortization of 4.9 M, as well as many indicators such as Price To Sales Ratio of 87.97, Dividend Yield of 0.0 or PTB Ratio of 1.98. Shattuck financial statements analysis is a perfect complement when working with Shattuck Labs Valuation or Volatility modules.
  
Check out the analysis of Shattuck Labs Correlation against competitors.
For more information on how to buy Shattuck Stock please use our How to buy in Shattuck Stock guide.

Latest Shattuck Labs' Market Capitalization Growth Pattern

Below is the plot of the Market Cap of Shattuck Labs over the last few years. It is Shattuck Labs' Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Shattuck Labs' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 91.66 M10 Years Trend
Pretty Stable
   Market Cap   
       Timeline  

Shattuck Market Capitalization Regression Statistics

Arithmetic Mean441,045,653
Geometric Mean340,453,875
Coefficient Of Variation110.40
Mean Deviation264,336,342
Median291,100,723
Standard Deviation486,926,738
Sample Variance237097.6T
Range2.1B
R-Value0.16
Mean Square Error247362.7T
R-Squared0.03
Significance0.55
Slope16,573,147
Total Sum of Squares3556464.7T

Shattuck Market Capitalization History

2025331.8 M
2024349.3 M
2023303.7 M
202297.5 M
2021357.7 M
20202.2 B
2019807.8 M

About Shattuck Labs Financial Statements

Shattuck Labs investors utilize fundamental indicators, such as Market Capitalization, to predict how Shattuck Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company was incorporated in 2016 and is headquartered in Austin, Texas. Shattuck Labs operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 85 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Shattuck Labs is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Shattuck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Shattuck Labs Stock. Highlighted below are key reports to facilitate an investment decision about Shattuck Labs Stock:
Check out the analysis of Shattuck Labs Correlation against competitors.
For more information on how to buy Shattuck Stock please use our How to buy in Shattuck Stock guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shattuck Labs. If investors know Shattuck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shattuck Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.15)
Revenue Per Share
0.132
Quarterly Revenue Growth
3.369
Return On Assets
(0.41)
Return On Equity
(0.71)
The market value of Shattuck Labs is measured differently than its book value, which is the value of Shattuck that is recorded on the company's balance sheet. Investors also form their own opinion of Shattuck Labs' value that differs from its market value or its book value, called intrinsic value, which is Shattuck Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shattuck Labs' market value can be influenced by many factors that don't directly affect Shattuck Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shattuck Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shattuck Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shattuck Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.